Abstract
Objective: Our aim was to determine if a once-a-week folic acid supplement increases women's red blood cell folate to concentrations (>905 nmol/l) that are associated with a low risk of bearing a child with a neural tube defect.
Design: Randomized control trial.
Setting: General community.
Subjects: In total, 114 nonpregnant women (18–40 y) volunteers, with red blood cell folate concentrations between 295 and 905 nmol/l at screening.
Interventions: Women were randomized to receive a once-a-week 2800 μg folic acid supplement, a daily 400 μg folic acid supplement or a daily placebo for 12 weeks.
Results: The mean (95% CI) red blood cell folate concentrations increased during the 12-week intervention from 608 (553–668) to 900 (828–978) in the weekly folic acid group (P<0.05) and from 615 (560–677) to 1053 (957–1158) nmol/l in the daily group (P<0.05) during the trial. At week 12, 49% of women ingesting the weekly folic acid supplement had red blood cell folate concentrations greater than 905 nmol/l compared to 74% of women ingesting the daily supplement.
Conclusions: A once-a-week 2800 μg folic acid supplement can increase women's red blood cell folate to concentrations associated with a reduced risk of bearing a child with a neural tube defect, but is less effective than a 400 μg daily supplement. Use of a weekly folic acid supplement over at least 12 weeks before conception by women of child-bearing age may prevent neural tube defects.
Funding: The Otago Medical Research Foundation (Laurenson Award). Healtheries (New Zealand) provided the supplements.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adank C, Green TJ, Skeaff CM & Briars B (2003): Weekly high dose folic acid supplementation is effective in lowering serum homocysteine concentration in women. Ann. Nutr. Metab. 47, 55–59.
Anonymous (1996): Food standard: amendment of the standards of identity for enriched grain products to require addition of folic acid. US Department of Health and Human Services, Food and Drug Administration. Fed. Regist. 61, 8781–8809.
Anonymous (1999): Knowledge and use of folic acid by women of childbearing age—United States, 1995 and 1998. MMWR—Morbid. Mortal. Weekly Report 48, 325–327.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX & Correa A (1999): Prevention of neural-tube defects with folic acid in China. China–US Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 341, 1485–1490.
Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH & Jacques PF (2002): Folic acid intake from fortification in United States exceeds predictions. J. Nutr. 132, 2792–2798.
Cornel MC, Erickson JD & van der Veen WJ (1997): Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 55, 134–137.
Czeizel AE & Dudas I (1992): Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327, 1832–1835.
Daly LE, Kirke PN, Molloy A, Weir DG & Scott JM (1995): Folate levels and neural tube defects. Implications for preventions. JAMA 274, 1698–1702.
Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG & Scott JM (1997): Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 350, 1666–1669.
Food and Nutrition Board (1998): Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, pantothenic acid, Biotin, and Choline. pp 273–283 Washington: Institute of Medicine.
Forrest JD (1994): Epidemiology of unintended pregnancy and contraceptive use. Am. J. Obstet. Gynecol. 170, 1485–1489.
Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD & Wong LY (2001): Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285, 2981–2986.
Mills JL (2000): Fortification of foods with folic acid—how much is enough? N. Engl. J. Med. 342, 1442–1445.
MRC Vitamin Study Research Group (1991): Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338, 131–137.
O'Broin S & Kelleher B (1992): Microbiological assay on microtitre plates of folate in serum and red cells. J. Clin. Pathol. 45, 344–347.
Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR & Cole DE (2002): Association of neural tube defects and folic acid food fortification in Canada. Lancet 360, 2047–2048.
Schader I & Corwin P (1999): How many pregnant women in Christchurch are using folic acid supplements in early pregnancy? N. Z. Med. J. 112, 463–465.
Schorah CJ, Devitt H, Lucock M & Dowell AC (1998): The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur. J. Clin. Nutr. 52, 407–411.
Skeaff M & Mann J (1998): Should folate be added to flour to prevent neural tube defects? N. Z. Med. J. 111, 417–418.
Smith C (2001): Dietary Supplement Use in the 1997. Otago: New Zealand National Nutrition Survey.
Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ & Wild J (1983): Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1, 1027–1031.
Wright JD, Bialostosky K, Gunter EW, Carroll MD, Najjar MF, Bowman BA & Johnson CL (1988): Blood folate and vitamin B12: United States, 1988–94. National Centre for Health Statistics. Vital Health Stat. 11, 243.
Acknowledgements
We thank Sean O'Broin for advice on the microbiological assay; Margaret Waldron for blood collection; Steven Tzisavari, Ashley Duncan and Christian Thoma for their support with the laboratory analysis; Joanne Mackenzie for statistical advice.
Author information
Authors and Affiliations
Contributions
Guarantor: CM Skeaff.
Contributors: CMS and TG had the original idea and obtained funds for the project. All authors were responsible for planning the study. BN and CA recruited subjects and were responsible for sample collection and laboratory analysis. All authors contributed to statistical analysis and writing of the report.
Corresponding author
Rights and permissions
About this article
Cite this article
Norsworthy, B., Skeaff, C., Adank, C. et al. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 58, 548–554 (2004). https://doi.org/10.1038/sj.ejcn.1601843
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601843
Keywords
This article is cited by
-
Global strategies for the prevention of neural tube defects through the improvement of folate status in women of reproductive age
Child's Nervous System (2023)
-
The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects
Scientific Reports (2018)
-
A review of European guidelines on periconceptional folic acid supplementation
European Journal of Clinical Nutrition (2016)
-
Knowledge about folic acid supplementation in women presenting for antenatal care
European Journal of Clinical Nutrition (2016)
-
Rationale, design, methodology and sample characteristics for the Vietnam pre-conceptual micronutrient supplementation trial (PRECONCEPT): a randomized controlled study
BMC Public Health (2012)